A multi-center, randomized, double-blind, placebo-controlled, parallel group, polysomnography study to investigate safety and efficacy of the rotigotine transdermal patch in subjects with Restless Legs Syndrome and End-Stage Renal Disease requiring hemodi
Read time: 1 mins
Last updated:10th Jan 2012
The primary objective of this trial is to demonstrate superiority of rotigotine against placebo in subjects with RLS and ESRD requiring hemodialysis.
|Study start date||2012-01-10|